What is the current Global Anthrax Vaccine Market size?

The Global Anthrax Vaccine Market is projected to register a CAGR of 7.60% during the forecast period (2024-2029) Read More

Who are the key players in Global Anthrax Vaccine Market?

Colondo Serum Company , Merck Co, Inc. (MSD Animal Health), Emergent BioSolutions Inc. , Proton Biopharma Ltd and Altimmune (Pharmathene Inc.) are the major companies operating in the Global Anthrax Vaccine Market. Read More

Which is the fastest growing region in Global Anthrax Vaccine Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Anthrax Vaccine Market?

In 2024, the North America accounts for the largest market share in Global Anthrax Vaccine Market. Read More

What years does this Global Anthrax Vaccine Market cover?

The report covers the Global Anthrax Vaccine Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Anthrax Vaccine Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Anthrax Vaccine Market Size & Share Analysis - Industry Research Report

Anthrax Vaccine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Anthrax Vaccine Market is Segmented by Vaccine Type (Cell-Free PA Vaccine and Live Attenuated Vaccine), Application Type (Animal Use and Human Use), Distribution Channel (Hospitals, Pharmacies, and Other Distribution Channels), and Geography (North America, Europe, Asia Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Anthrax Vaccine Industry Overview

The anthrax vaccine market is consolidated with a few market players in the human and animal segments. In terms of market share, major players dominate the market. With the rising prevalence of disease and increasing awareness among the public, many new players may enter the market over the forecast period. Some market players are Emergent Bio Solutions Inc., Altimmune (Pharmathene Inc.), Proton Biopharma Ltd., Colorado Serum Company, Bayer AG, and Merck & Co. Inc.